2YN8
ephB4 kinase domain inhibitor complex
2YN8 の概要
| エントリーDOI | 10.2210/pdb2yn8/pdb |
| 関連するPDBエントリー | 2BBA 2VWU 2VWV 2VWW 2VWX 2VWY 2VWZ 2VX0 2VX1 2X9F 2XVD 4AW5 4BB4 |
| 分子名称 | EPHRIN TYPE-B RECEPTOR 4, STAUROSPORINE (3 entities in total) |
| 機能のキーワード | transferase, unphosphorylated |
| 由来する生物種 | HOMO SAPIENS (HUMAN) |
| タンパク質・核酸の鎖数 | 2 |
| 化学式量合計 | 67995.69 |
| 構造登録者 | |
| 主引用文献 | Overman, R.C.,Green, I.,Truman, C.M.,Read, J.A.,Embrey, K.J.,Mcalister, M.S.B.,Attwood, T.K. Stability and Solubility Engineering of the Ephb4 Tyrosine Kinase Catalytic Domain Using a Rationally Designed Synthetic Library. Protein Eng.Des.Sel., 26:695-, 2013 Cited by PubMed Abstract: The inability to generate soluble, correctly folded recombinant protein is often a barrier to successful structural and functional studies. Access to affordable synthetic genes has, however, made it possible to design, make and test many more variants of a target protein to identify suitable constructs. We have used rational design and gene synthesis to create a controlled randomised library of the EphB4 receptor tyrosine kinase, with the aim of obtaining soluble, purifiable and active catalytic domain material at multi-milligram levels in Escherichia coli. Three main parameters were tested in designing the library--construct length, functional mutations and stability grafting. These variables were combined to generate a total of 9720 possible variants. The screening of 480 clones generated a 3% hit rate, with a purifiable solubility of up to 15 mg/L for some EphB4 constructs that was largely independent of construct length. Sequencing of the positive clones revealed a pair of hydrophobic core mutations that were key to obtaining soluble material. A minimal kinase domain construct containing these two mutations exhibited a +4.5°C increase in thermal stability over the wild-type protein. These approaches will be broadly applicable for solubility engineering of many different protein target classes. Atomic coordinates and structural factors have been deposited in PDB under the accession 2yn8 (EphB4 HP + staurosporine). PubMed: 23840071DOI: 10.1093/PROTEIN/GZT032 主引用文献が同じPDBエントリー |
| 実験手法 | X-RAY DIFFRACTION (2.11 Å) |
構造検証レポート
検証レポート(詳細版)
をダウンロード






